Vote Scores

Home / Companies / Alembic Pharmaceuticals Limited / 22 Jul 2024

Meeting · year to 30 June 202521 filers reporting

Alembic Pharmaceuticals Limited: meeting of 22 Jul 2024

Votes reported on Form N-PX, item by item

21 Form N-PX filers reported votes at the Alembic Pharmaceuticals Limited meeting of 22 Jul 2024. Their records fall into 5 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

1 nominee; 100.0% of reported votes for; no filer withheld from or voted against at least one nominee.

29 vote records from 21 filers. 0 of the 21 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management21 filers
2

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

5 vote records from 4 filers. 0 of the 4 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management4 filers100.0% for0.0% against0.0% against management746,899 reported shares
3

CAPITAL STRUCTUREIssuer

CAPITAL STRUCTURE: management items

Management items in this category are shown together; filers word and number them differently.

29 vote records from 21 filers. 0 of the 21 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management21 filers100.0% for0.0% against0.0% against management3,333,279 reported shares, counted once per item in this group
4

COMPENSATIONIssuer

COMPENSATION: management items

Management items in this category are shown together; filers word and number them differently.

24 vote records from 17 filers. 0 of the 17 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management17 filers100.0% for0.0% against0.0% against management2,586,380 reported shares, counted once per item in this group
5

CORPORATE GOVERNANCEIssuer

CORPORATE GOVERNANCE: management items

Management items in this category are shown together; filers word and number them differently.

28 vote records from 20 filers. 19 of the 20 filers that marked the item either way voted against management.

0.0% for100.0% against95.0% against management20 filers0.0% for100.0% against99.9% against management3,331,084 reported shares, counted once per item in this group

How the largest families voted

Family1. Directors2. Auditor
VanguardForNo report
BlackRock and iSharesForFor
FidelityForNo report
DimensionalForNo report
State Street and SPDRForNo report
American CenturyForNo report
Nuveen and TIAAForNo report
WisdomTreeForNo report
Northern Trust and FlexSharesForNo report
SEIForFor

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Alembic Pharmaceuticals Limited meeting?

21 Form N-PX filers reported votes at the meeting of 22 Jul 2024. The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Alembic Pharmaceuticals Limited on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Alembic Pharmaceuticals Limited

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Alembic Pharmaceuticals Limited with a meeting date within three days of 22 Jul 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 30 Sep 2026.